Hasegawa W[au] - Search Results

Year	Number of Results
1969	1
2001	1
2002	1
2003	4
2005	3
2007	1
2008	1
2011	1
2014	4
2015	5
2016	4
2017	5
2018	5
2019	3
2020	4
2021	2

1

Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer.

Nakagawa K, Hida T, Nokihara H, Morise M, Azuma K, Kim YH, Seto T, Takiguchi Y, Nishio M, Yoshioka H, Kumagai T, Hotta K, Watanabe S, Goto K, Satouchi M, Kozuki T, Koyama R, Mitsudomi T, Yamamoto N, Asakawa T, Hayashi M, Hasegawa W, Tamura T. Nakagawa K, et al. Among authors: hasegawa w. Lung Cancer. 2020 Jan;139:195-199. doi: 10.1016/j.lungcan.2019.11.025. Epub 2019 Nov 28. Lung Cancer. 2020. PMID: 31812890

2

The predictive value of intracellular imatinib levels in newly diagnosed chronic myeloid leukemia.

Hillis CM, Jackson Chornenki NL, Bence-Bruckler I, Busque L, Cote Y, Hamm C, Hasegawa W, Kamel-Reid S, Savoie L, Turner AR, Xenocostas A, Lipton JH, Leber B. Hillis CM, et al. Among authors: hasegawa w. Leuk Res. 2020 Jan;88:106285. doi: 10.1016/j.leukres.2019.106285. Epub 2019 Dec 5. Leuk Res. 2020. PMID: 31846781 No abstract available.

3

Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study.

Jo T, Yasunaga H, Yamauchi Y, Mitani A, Hiraishi Y, Hasegawa W, Sakamoto Y, Matsui H, Fushimi K, Nagase T. Jo T, et al. Among authors: hasegawa w. ERJ Open Res. 2020 Feb 3;6(1):00246-2019. doi: 10.1183/23120541.00246-2019. eCollection 2020 Jan. ERJ Open Res. 2020. PMID: 32039260 Free PMC article.

4

Influence of Parkinsonism on outcomes of elderly pneumonia patients.

Jo T, Yasunaga H, Michihata N, Sasabuchi Y, Hasegawa W, Takeshima H, Sakamoto Y, Matsui H, Fushimi K, Nagase T, Yamauchi Y. Jo T, et al. Among authors: hasegawa w. Parkinsonism Relat Disord. 2018 Sep;54:25-29. doi: 10.1016/j.parkreldis.2018.03.028. Epub 2018 Apr 3. Parkinsonism Relat Disord. 2018. PMID: 29627432

5

Iron overload in myelodysplastic syndromes: a Canadian consensus guideline.

Wells RA, Leber B, Buckstein R, Lipton JH, Hasegawa W, Grewal K, Yee K, Olney HJ, Larratt L, Vickars L, Tinmouth A. Wells RA, et al. Among authors: hasegawa w. Leuk Res. 2008 Sep;32(9):1338-53. doi: 10.1016/j.leukres.2008.02.021. Epub 2008 Apr 11. Leuk Res. 2008. PMID: 18405971

6

IND.216: a phase II study of buparlisib and associated biomarkers, raptor and p70S6K, in patients with relapsed and refractory chronic lymphocytic leukemia.

Assouline S, Amrein L, Aloyz R, Banerji V, Caplan S, Owen C, Hasegawa W, Robinson S, Shivakumar S, Prica A, Peters A, Hagerman L, Rodriguez L, Skamene T, Panasci L, Chen BE, Hay AE. Assouline S, et al. Among authors: hasegawa w. Leuk Lymphoma. 2020 Jul;61(7):1653-1659. doi: 10.1080/10428194.2020.1734594. Epub 2020 Mar 10. Leuk Lymphoma. 2020. PMID: 32154751 Clinical Trial.

7

Prognostic nomogram for inpatients with asthma exacerbation.

Hasegawa W, Yamauchi Y, Yasunaga H, Takeshima H, Sakamoto Y, Jo T, Sasabuchi Y, Matsui H, Fushimi K, Nagase T. Hasegawa W, et al. BMC Pulm Med. 2017 Aug 4;17(1):108. doi: 10.1186/s12890-017-0450-2. BMC Pulm Med. 2017. PMID: 28778188 Free PMC article.

8

Mortality associated with bone fractures in COPD patients.

Yamauchi Y, Yasunaga H, Sakamoto Y, Hasegawa W, Takeshima H, Urushiyama H, Jo T, Matsui H, Fushimi K, Nagase T. Yamauchi Y, et al. Among authors: hasegawa w. Int J Chron Obstruct Pulmon Dis. 2016 Sep 21;11:2335-2340. doi: 10.2147/COPD.S112142. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27703343 Free PMC article.

9

Venous thromboembolic events in patients with lung cancer treated with cisplatin-based versus carboplatin/nedaplatin-based chemotherapy.

Mitani A, Jo T, Yasunaga H, Sakamoto Y, Hasegawa W, Urushiyama H, Yamauchi Y, Matsui H, Fushimi K, Nagase T. Mitani A, et al. Among authors: hasegawa w. Anticancer Drugs. 2018 Jul;29(6):560-564. doi: 10.1097/CAD.0000000000000625. Anticancer Drugs. 2018. PMID: 29570101

10

Effect of Hangeshashin-To (Japanese Herbal Medicine Tj-14) on Tolerability of Irinotecan: Propensity Score and Instrumental Variable Analyses.

Urushiyama H, Jo T, Yasunaga H, Michihata N, Yamana H, Matsui H, Hasegawa W, Hiraishi Y, Mitani A, Fushimi K, Nagase T, Yamauchi Y. Urushiyama H, et al. Among authors: hasegawa w. J Clin Med. 2018 Aug 28;7(9):246. doi: 10.3390/jcm7090246. J Clin Med. 2018. PMID: 30154384 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results